Arkansas Department of Finance and Administration

Charlie Baker Joins UnitedHealth Group’s Board of Directors

Retrieved on: 
Friday, November 3, 2023
General Health, Health, Health Technology, Managed Care, Health Insurance, Harvard Pilgrim Health Care, NYSE, Government, Human services, UnitedHealth Group, Administration, National Collegiate Athletic Association, UNH, United States Department of Health and Human Services, Arkansas Department of Finance and Administration, Patient, Management

UnitedHealth Group (NYSE: UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately.

Key Points: 
  • UnitedHealth Group (NYSE: UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately.
  • “Charlie Baker’s leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone,” said UnitedHealth Group Board Chairman Stephen J. Hemsley.
  • “Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits.”
    “UnitedHealth Group has unique capabilities to improve health care outcomes, lower costs and make the experience better for both patients and providers,” Baker said.
  • “I am honored to join such a distinguished board and excited to help accelerate the company’s work.”
    Baker is the current president of the National Collegiate Athletic Association.

EQS-News: Salzgitter Aktiengesellschaft: Salzgitter AG appoints new female Executive Board member, Birgit Potrafki to succeed Burkard Becker as CFO

Retrieved on: 
Friday, August 4, 2023
Worcester, Bosch Group, Becker, Arkansas Department of Finance and Administration, Executive, Robert Bosch GmbH, Supervisory board, Orientation, Salzgitter AG, Salzgitter, Administration, RTÉ Executive Board, Smart electric drive, Leibniz University Hannover, CFO, Knowledge, Economics, Female, Management

Salzgitter Aktiengesellschaft: Salzgitter AG appoints new female Executive Board member, Birgit Potrafki to succeed Burkard Becker as CFO

Key Points: 
  • Salzgitter Aktiengesellschaft: Salzgitter AG appoints new female Executive Board member, Birgit Potrafki to succeed Burkard Becker as CFO
    The issuer is solely responsible for the content of this announcement.
  • Salzgitter.
  • At a meeting on 16.06.2023, the Supervisory Board of Salzgitter AG appointed Ms. Birgit Potrafki (52) as a new member of the Executive Board.
  • She will join the Board on 01.02.2024 and take up the position of CFO on 01.04.2024.

Intellia Therapeutics Names Bill Chase to its Board of Directors

Retrieved on: 
Monday, April 17, 2023
CRISPR, Arkansas Department of Finance and Administration, University, NTLA, Abbott, Abbott Laboratories, Business, MBA, Parexel, David G. Booth, Administration, Business administration, Retirement, AbbVie, Champaign–Urbana metropolitan area, Master of Business Administration, Therapy, Financial management, Management, Intellia Therapeutics

CAMBRIDGE, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies leveraging CRISPR-based technologies, today announced the appointment of Bill Chase, MBA, to its board of directors.

Key Points: 
  • CAMBRIDGE, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies leveraging CRISPR-based technologies, today announced the appointment of Bill Chase, MBA, to its board of directors.
  • Mr. Chase will be a member of the audit committee and will succeed Caroline Dorsa as chair of the audit committee upon her retirement from the board.
  • Ms. Dorsa is retiring from Intellia’s board, effective June 15, 2023, as a result of her appointment as chair of Biogen’s board of directors.
  • He also serves on the board of Parexel International, one of the industry’s largest clinical research organizations.